Dental laser company Biolase has entered a securities purchase agreement valued at $6.5 million.
Biolase entered the deal with an unnamed institutional investor, according to a June 28 news release.
Under the terms of the agreement, Biolase will sell 1,405,405 shares of common stock or pre-funded warrants in a registered direct offering. The company will also issue warrants to purchase common stock in a private placement.
The deal is expected to close on or about June 30.